Safety, adverse events and adherence
night sweats
ADVERSE EVENTS, ADVERSE EVENT, ADVERSE EVENT, BLIND
All adverse events were systematically collected monthly and blindly adjudicated for a potential relationship with progesterone therapy. No Adverse events on oral micronized progesterone (300 mg at bedtime) or Placebo in perimenopausal women participating in a randomized double blind 12-Week trial for hot flushes and night sweats (n = 189).*Discontinuation related to an adverse event on placebo.**Family Physician-mandated discontinuation from progesterone experimental therapy.^The only experience potentially related to progesterone therapy in blinded adjudication.